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Introduction
1
With a lifetime prevalence of around 25% of the overall population, mental disorders are 2 highly prevalent [1] . Patients with mental disorders suffer from substantial impairments of 3 quality of life and reduced ability to participate in professional and social life [2] . Around 35 4 to 50% of patients with serious mental illness do not receive treatment in developed countries 5 [3]. After onset of a mental disorder, there is often a delay of several years until first treatment 6 is initiated [4] . In addition, among those who receive treatment, rates of nonresponse and 7 relapse are relatively high: for major depression, for example, relapse rates after cognitive 8 behavior therapy or antidepressant medication are around 50% [5, 6] .
9
For economic and practical reasons, it seems reasonable to implement preventive strategies 10 predominantly in those at elevated risk for the onset of a mental disorder. Insomnia, a 11 syndrome characterized by chronic sleep onset and/or sleep continuity problems associated 12 with impairment of daytime functioning, has the potential to serve as an indicator for an 13 elevated risk. Pathophysiologically, insomnia is associated with cognitive and physiological 14 hyperarousal [7, 8] increased pre-occupation with sleep [9] and maladaptive sleep-related 15 behavior [10] . Insomnia has been identified as a predictor for the de-novo onset of major 16 depression in two meta-analyses [11, 12] . The effect sizes (odds ratios) found in these two 17 meta analyses were 2.60 (95% CI: 1.98-3.42) and 2.27 (95% CI: 1.89-2.71). However, in 18 these previous meta-analyses, some primary studies included participants with only nighttime 19 symptoms without daytime symptoms, though daytime symptoms are a necessary requirement 20 for the diagnosis of insomnia disorder. This is a limitation since in clinical practice, nighttime 21 symptoms such as difficulties initiating and maintaining sleep are commonly reported, but do 22 not require medical or psychological interventions in the absence of any daytime impairment.
23
Clinical insomnia with daytime impairment, in contrast, is treated with either 24 pharmacotherapy or psychotherapy [13] . Insomnia is also a frequent symptom of almost all 25 M A N U S C R I P T
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5 mental disorders [14] . Several studies indicate that insomnia may also be a risk factor for 1 other psychiatric symptoms beyond depression, including anxiety and suicide [15] .
2
This opens up the possibility to use treatment of insomnia for the prevention of mental 3 disorders. Insomnia is well treatable, the first-line treatment being cognitive behavioral 4 treatment for insomnia [16] [17] [18] . CBT-I is a treatment package including behavioral 5 techniques, relaxation, and cognitive therapy. With CBT-I, insomnia symptoms can be 6 significantly reduced in the short-and long-term [19] . As first step into prevention, the 7 question whether insomnia predicts the later onset of different mental disorders has to be 8 answered.
9
To the best of our knowledge, no meta-analysis investigating insomnia, including daytime 10 symptoms, as a potential risk factor for different psychiatric symptoms or disorders has yet 11 been performed. The objective of the present study was to quantitatively summarize 12 longitudinal studies investigating whether insomnia at baseline constitutes a risk factor for the 13 later onset of a mental disorder.
15
Methods
16
The meta-analysis was performed in accordance with the recommendations of reporting for 17 meta-analyses of observational studies in epidemiology [MOOSE, 20] search, screened all titles and, where applicable, the abstracts and full texts of potentially 21 eligible studies, and extracted relevant data for the analyses from the full texts of selected 22 studies. Doubts were discussed together with the first and the last author (EH and CB) and OR 'epidemiolog*' OR 'prospective' OR 'risk factor'). The literature search was performed 4 using the databases PubMed, Medline, PsycInfo, and PsycArticles.
5
In addition, for insomnia as a predictor of depression, eligible studies from our previous meta- 'depression' AND 'longitudinal' OR 'epidemiolog*' OR 'prospective' OR 'risk factor'.
12
Appendix S1 reports the full information on the search strategy. The following inclusion criteria for primary studies were applied: Meta-analyses examining the predictive value of presence of insomnia at baseline for 8 presence of psychopathology at follow-up were performed for depression (n = 10), anxiety 9 disorders (n = 6), alcohol abuse (n = 2), and psychotic disorders (n = 1) . Several studies were 10 included with more than one outcome. As an exploratory analysis, a pooled effect size across 11 all mental disorders was performed. If a primary study had more than one follow-up, the last 12 follow-up was used for the analysis. The logarithms (logs) of the odds ratios (ORs) and their
13
95% confidence intervals (CIs) were used for meta-analytic calculations. Assuming that there 14 is a distribution of true effect sizes rather than a single true effect size, a random-effects model 15 was selected for meta-analytic pooling of the primary studies [22] . As a test for heterogeneity, 
Assessment of risk of bias
22
The QUIPS (Quality in Prognosis Studies) Risk of Bias Assessment Instrument for Prognostic
23
Factor Studies was used as a tool for the assessment of risk of bias in the individual studies
24
[23]. The tool provides criteria for assessing risk of bias for each study on six dimensions: 25 study participation, attrition, prognostic factor measurement, outcome measurement,
confounders, and statistical analysis. On the basis of predefined criteria, risk of bias is rated as 1 low, medium or high. For the present study, the assessment tool was applied by two 2 independent raters (TG and CK). After each rater had completed their work, results were 3 compared and disagreements were resolved by discussion with a third rater (CB 
Results
18
The process of study identification, screening for eligibility, and inclusion is shown in figure   19 1. 
Main Results
10
The results of the meta-analysis are shown in figure 2. The main result is that insomnia is a studies, but not for depression in longer follow-up studies.
24
In addition, primary studies were divided in those including only participants free of any 25 mental disorders at baseline ("pure" studies), and those allowing for comorbidity at baseline
and performing a statistical control. We found 11 "pure" studies and two with statistical 1 control. Insomnia as a predictor of mental disorders remained significant in the sample of 11 2 "pure" studies. Heterogeneity, however, was still significant in this subgroup. confounders was assessed, or because the validity of the measurement was questionable.
25
Finally, concerning the statistical analysis, risk of bias was rated as low for most studies. plots indicated a certain degree of asymmetry, e.g. that publication bias cannot be excluded. 
Discussion
16
The present meta-analysis including 13 primary studies evaluated the predictive power of 17 insomnia at baseline for the onset of a mental disorder within the follow-up period. We found 18 that insomnia is a significant predictor for depression, anxiety, and alcohol abuse. One study
19
suggested that insomnia is also a predictor of psychosis. This result remained significant when To our knowledge, the present study is the first meta-analysis investigating insomnia as a manifesting itself e.g. in increased fast frequency EEG activity or an increased heart rate, is a 25 known biomarker of insomnia [7, 8] . Alterations in brain arousal states are also associated with is associated with an increased risk for mental disorders [42] . Most likely, insomnia plays an 4 important part as a risk factor in this process.
5
The neuroplasticity hypothesis also can, at least in part, explain how insomnia could 6 contribute to depression. According to this hypothesis, a dysfunction of synaptic plasticity is a 7 major pathomechanism of depression [43] . Synaptic plasticity is the neurobiological 8 mechanism by which the brain adapts to learning tasks and an ever changing environment investigating long term anxiety, but four investigating long term depression.
17
The present meta-analysis has several strengths and limitations. An important characteristic of 18 our study is that the presence of both daytime and nighttime symptoms of insomnia at to the onset of mental disorders, early treatment of insomnia would be likely to reduce the risk 8 of later psychopathology. However, it cannot be excluded that insomnia is simply an early 9 symptom which is not causally linked to the later onset or progress of a mental illness. In this 10 case, early insomnia treatment would still be needed in order to alleviate the symptoms of 11 insomnia itself -however, benefits in terms of prevention would be limited in this case. In an
12
Australian clinical trial [55] patients with insomnia who did not meet criteria for major 13 depression at baseline were randomized to CBT-I or a placebo intervention. In this trial, CBT-
14
I was delivered in the form of an online self-help program. At 6-month follow-up, the 15 incidence rate of major depressive episode was not significantly different in the two groups.
16
This lack of significant effect may be due to the low total incidence rate (4%), indicating that 17 the follow-up period of 6 months may have been too short to display differences. An 18 alternative explanation is that the intervention was too weak to have a preventive effect.
19
CBT-I was more effective than the placebo in the reduction of subclinical depressive 20 symptoms (i.e., subjects exhibiting some depressive symptoms, but not meeting criteria for 21 major depressive disorder), suggesting that there is some kind of effect on psychopathology 
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In conclusion, this meta-analysis provides evidence that insomnia increases the odds for the 1 future onset of psychopathology. In our literature search, we found that previous research has 2 focused on depression and anxiety, whereas research into other mental disorders is scarce. In 
Practice Points
11
• Insomnia is a predictor for the future onset of depression, anxiety, and alcohol abuse, and 12 a potential predictor of psychotic symptoms.
13
• We recommend screening patients with insomnia for mental disorders. A. Included primary studies were divided in those with a shorter follow-up duration (12-24 4 months) and a longer follow up duration (> 24 months).
5
B. Primary studies were divided in those including only participants free of any mental 6 disorders at baseline ("pure"), and those allowing for comorbidity at baseline and 7 performing a statistical control ("stat"). Funnel plots for the assessment of publication bias. Each dot represents one included study.
11
Egger's tests were insignificant, indicating that funnel plots were not asymmetric (depression: 
